Israel Archives - MEDIC NEST

IsraelRevealing the immune tumor microenvironment (iTME) in melanoma by multiplexed imaging

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2025 Topic: Tool Project type: Preclinic Immunotherapy Theranostic Project target: Skin Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: WEIZMANN INSTITUTE OF SCIENCE Keywords: oncology; melanoma; tumour; protein; immunotherapy; Itme; microenviroment; machine learning; platform Countries: Israel Project page: Access page

Belgium France Germany Ireland Israel Italy Netherlands Portugal South Africa Spain Sweden Switzerland UK USAAutism Innovative Medicine Studies 2 Trials

July 19, 2022by pcdata

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

Austria France Germany Greece Israel Netherlands Romania Switzerland United KingdomImmunoSep: Advancing Personalised Immunotherapy in Sepsis

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2023 Topic: Biomarkers identification Project type: Immunotherapy Project target: Autoimmune disease Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: Radboud University Medical Center -ELLINIKO INSTITUTO MELETIS TIS SIPSIS -CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS -UNIVERSITATSKLINIKUM JENA -ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT...